Cita APA (7a ed.)
F, D., B, R., S, S., G, D. L., J, D., P, R., . . . JY, B. (2008). Plasminogen activator inhibitor type 1 is the most significant of the usual tissue prognostic factors in node-negative breast ductal adenocarcinoma independent of urokinase-type plasminogen activator. Clinical Breast Cancer, 8(2), 168-178.
Cita Chicago Style (17a ed.)
F, Descotes, Riche B, Saez S, De Laroche G, Datchary J, Roy P, André J, y Bobin JY. "Plasminogen Activator Inhibitor Type 1 Is the Most Significant of the Usual Tissue Prognostic Factors in Node-negative Breast Ductal Adenocarcinoma Independent of Urokinase-type Plasminogen Activator." Clinical Breast Cancer 8, no. 2 (2008): 168-178.
Cita MLA (9a ed.)
F, Descotes, et al. "Plasminogen Activator Inhibitor Type 1 Is the Most Significant of the Usual Tissue Prognostic Factors in Node-negative Breast Ductal Adenocarcinoma Independent of Urokinase-type Plasminogen Activator." Clinical Breast Cancer, vol. 8, no. 2, 2008, pp. 168-178.
Precaución: Estas citas no son 100% exactas.